Correlations Between Subjective Evaluation of Quality of Life, Visual Field Loss, and Performance in Simulated Activities of Daily Living in Glaucoma Patients.


Journal

Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 11 7 2020
medline: 23 1 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

Glaucoma patients displayed alterations in their quality of life (QoL) and their ability to perform activities of daily living. The visual field (VF) of the worse eye might serve as a good marker for QoL evaluation. The purpose of this study was to explore the correlations between VF defects, performance in simulated activities of daily living, and subjective evaluation of QoL in glaucoma patients. Thirty-two patients with glaucoma and 10 age-matched control subjects were included. All participants answered a QoL questionnaire and underwent an assessment of visual function including monocular and binocular best-corrected visual acuity, binocular contrast sensitivity test (LogCS), and monocular and binocular VF. All subjects also carried out a series of simulated activities of daily living in a controlled environment. Glaucoma patients had lower QoL scores compared with controls for the composite score, near and distance activities, social functioning, mental health, role difficulties, dependency, and color vision. With regard to performance in the simulated mobility task, the number of mobility incidents was higher for glaucoma patients than for control subjects. For the reaching and grasping tasks, the overall movement duration for small objects was significantly longer in glaucoma patients compared with controls. The VF mean deviation of the worse eye was correlated with most of the QoL subscores. Mobility incidents as well as the reaching and grasping task parameters were not significantly correlated with QoL scores. Glaucoma patients showed an alteration of performance in simulated daily living activities, associated with a decreased QoL. There was no clear correlation between alterations in QoL and ability to perform activities of daily living. The QoL related to vision was mostly correlated to the visual function of the worse eye.

Identifiants

pubmed: 32649451
doi: 10.1097/IJG.0000000000001597
pii: 00061198-202010000-00021
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-974

Références

Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121:2081–2090.
Shon K, Wollstein G, Schuman JS, et al. Prediction of glaucomatous visual field progression: pointwise analysis. Curr Eye Res. 2014;39:705–710.
Sousa MC, Biteli LG, Dorairaj S, et al. Suitability of the Visual Field Index according to glaucoma severity. J Curr Glaucoma Pract. 2015;9:65–68.
Odberg T, Jakobsen JE, Hultgren SJ, et al. The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand. 2001;79:121–124.
Quaranta L, Riva I, Gerardi C, Oddone F. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33:959–981.
Brusini P, Johnson CA. Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol. 2007;52:156–179.
Alqudah A, Mansberger SL, Gardiner SK, et al. Vision-related quality of life in glaucoma suspect or early glaucoma patients. J Glaucoma. 2016;25:629–633.
Floriani I, Quaranta L, Rulli E, et al. Health-related quality of life in patients with primary open-angle glaucoma. An Italian multicentre observational study. Acta Ophthalmol. 2016;94:e278–e286.
Lombardi M, Zenouda A, Azoulay-sebban L, et al. Correlation between visual function and simulated performance of daily living activities in glaucomatous patients. J Glaucoma. 2018;27:1017–1024.
Hyman LG, Komaroff E, Heijl A, et al. Early Manifest Glaucoma Trial Group. Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology. 2005;112:1505–1513.
Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006;141:S3–S14.
Nelson P, Aspinall P, O’Brien C. Patients’ perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 1999;83:546–552.
Sippel K, Kasneci E, Aehling K, et al. Binocular glaucomatous visual field loss and its impact on visual exploration—a supermarket study. PLoS One. 2014;9:e106089.
McGwin G Jr, Huisingh C, Jain SG, et al. Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions. J Glaucoma. 2015;24:138–143.
Lisboa R, Chun YS, Zangwill LM, et al. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2013;131:486–494.
Esterman DB. Functional scoring of the binocular visual field. Ophthalmology. 1982;89:1226–1234.
Susanna R, Vessani RM. Staging glaucoma patient: why and how? Open Ophthalmol J. 2009;3:59–64.
Nordmann JP, Viala M, Sullivan K, et al. Psychometric validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics. 2004;22:197–206.
Suzukamo Y, Oshika T, Yuzawa M, et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes. 2005;3:65.
Ekici F, Loh R, Waisbourd M, et al. Relationships between measures of the ability to perform vision-related activities, vision-related quality of life, and clinical findings in patients with glaucoma. JAMA Ophthalmol. 2015;133:1377–1385.
Janz NK, Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: the collaborative initial glaucoma treatment study. Ophthalmology. 2001;108:887–897.
Mills RP, Janz NK, Wren PA, et al. Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma. 2001;10:192–198.
Viswanathan AC, McNaught AI, Poinoosawmy D, et al. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999;117:450–454.
Turano KA, Rubin GS, Quigley HA. Mobility performance in glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2803–2809.
Popescu ML, Boisjoly H, Schmaltz H, et al. Age-related eye disease and mobility limitations in older adults. Invest Ophthalmol Vis Sci. 2011;52:7168–7174.
Smith ND, Glen FC, Crabb DP. Eye movements during visual search in patients with glaucoma. BMC Ophthalmol. 2012;31:12–45.
Dakin S, Fiser J, Pasquale LR, et al. Effects of peripheral visual field loss on eye movements during visual sea-rch. Front Psychol. 2012;3:1–13.
Smith ND, Crabb DP, Garway-Heath DF. An exploratory study of visual search performance in glaucoma. Ophthalmic Physiol Opt. 2011;31:225–232.
Ramulu P. Glaucoma and disability : which tasks are affected, and at what stage of disease ? Curr Opin Ophthalmol. 2009;20:92–98.
Richman J, Lorenzana LL, Lankaranian D, et al. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol. 2010;17:144–151.
Murata H, Hirasawa H, Aoyama Y, et al. Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS One. 2013;8:e58695.
van Gestel A, Webers CAB, Beckers HJM, et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye. 2010;24:1759–1769.
Takahashi G, Otori Y, Urashima M, et al. Quality of Life Improvement Committee. Evaluation of quality of life in Japanese glaucoma patients and its relationship with visual function. J Glaucoma. 2016;25:e150–e156.
Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777–784.
Parrish RK, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115:1447–1455.
Sumi I, Shirato S, Matsumoto S, et al. The relationship between visual disability and visual field in patients with glaucoma. Ophthalmology. 2003;110:332–339.
Peters D, Heijl A, Brenner L, et al. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93:745–752.
Chelsea LR, Manju RP, Sujani S, et al. Glaucoma-associated visual task performance and vision-related quality of life in South India. Ophthalmol Glaucoma. 2019;2:357–363.
Sun Y, Lin C, Waisbourd M, et al. The impact of visual field clusters on performance-based measures and vision-related quality of life in patients with glaucoma. Am J Ophthalmol. 2016;163:45–52.

Auteurs

Line Azoulay-Sebban (L)

Streetlab, Institut de la Vision.

Zhanlin Zhao (Z)

Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine.
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

Ariel Zenouda (A)

Streetlab, Institut de la Vision.

Marco Lombardi (M)

Streetlab, Institut de la Vision.
Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DOS CIC 1423.

Emmanuel Gutman (E)

Streetlab, Institut de la Vision.

Emmanuelle Brasnu (E)

Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DOS CIC 1423.

Pascale Hamard (P)

Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DOS CIC 1423.

José-Alain Sahel (JA)

Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DOS CIC 1423.
iNSERM, U968; UPMC PARIS 06 University, UMR_S968, Institut de la Vision; CNRS, UMR 7210; Quinze-Vingts National Ophthalmology Hospital, INSERM-DHOS CIC 503.

Christophe Baudouin (C)

Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DOS CIC 1423.
iNSERM, U968; UPMC PARIS 06 University, UMR_S968, Institut de la Vision; CNRS, UMR 7210; Quinze-Vingts National Ophthalmology Hospital, INSERM-DHOS CIC 503.
Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT.
Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, Paris Saclay University, Paris, France.

Antoine Labbé (A)

Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DOS CIC 1423.
iNSERM, U968; UPMC PARIS 06 University, UMR_S968, Institut de la Vision; CNRS, UMR 7210; Quinze-Vingts National Ophthalmology Hospital, INSERM-DHOS CIC 503.
Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT.
Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, Paris Saclay University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH